Clinical Trial Update: Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study [Phase 2]

View source ↗

Summary

A Phase 2 feasibility study assessing olanzapine for preventing chemotherapy-induced nausea and vomiting in children has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 2 | Status: COMPLETED | Results posted: 2020-04-07